ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 142,91
0,83%
Dow Jones
38 884,26
0,00%
DAX
18 486,63
0,26%
Brent Oil
81,995
-1,05%
Bitcoin
62 417,28
0,13%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. HOOKIPA Pharma Inc (HOOK)

  7. HOOKIPA Pharma Inc (HOOK) Actualités

HOOK HOOKIPA Pharma Inc

0,827
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:51:20
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
HOOKIPA Pharma Inc HOOK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,827 13:51:20
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,827
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:01GLOBEHOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
24/4/202413:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
16/4/202422:30GLOBEHOOKIPA Pharma Announces Grant of Inducement Award Under..
10/4/202413:01GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
22/3/202412:01GLOBEHOOKIPA Pharma Reports Fourth Quarter and Full Year 2023..
06/3/202413:01GLOBEHOOKIPA Pharma to Participate in Leerink Partners Global..
31/1/202422:30EDGAR2Form 8-K - Current report
29/1/202414:12EDGAR2Form 8-K - Current report
29/1/202414:01GLOBEHOOKIPA Pharma Provides Update on Business Priorities and..
16/1/202413:01GLOBEHOOKIPA Pharma Appoints Mark Winderlich as Chief Development..
05/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/12/202313:33EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202313:06EDGAR2Form 8-K - Current report
21/12/202313:01GLOBEHOOKIPA Pharma Announces $21.25 Million Equity Investment..
01/12/202322:46EDGAR2Form 8-K - Current report
20/11/202313:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
09/11/202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:05EDGAR2Form 8-K - Current report
09/11/202313:01GLOBEHOOKIPA Pharma Reports Third Quarter 2023 Financial..
03/11/202317:01GLOBEHOOKIPA Pharma Presents Positive Biomarker and Translational..
02/11/202321:01GLOBEHOOKIPA Pharma to Report Third Quarter 2023 Financial..
22/10/202312:01GLOBEHOOKIPA Pharma Presents Additional Preliminary Phase 2 Data..
20/10/202322:05EDGAR2Form 8-K - Current report
18/10/202313:01GLOBEHOOKIPA Pharma announces publication of preclinical data of..
13/9/202314:47EDGAR2Form 8-K - Current report
13/9/202314:45GLOBEHOOKIPA Announces Executive Leadership Change
12/9/202314:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/9/202313:01GLOBEHOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
06/9/202313:01GLOBEHOOKIPA Pharma to participate in upcoming investor..
22/8/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:13EDGAR2Form SC TO-I - Tender offer statement by Issuer
10/8/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:05EDGAR2Form 8-K - Current report
10/8/202313:01GLOBEHOOKIPA Pharma Reports Second Quarter 2023 Financial Results..
04/8/202322:10EDGAR2Form 8-K - Current report
03/8/202313:01GLOBEHOOKIPA Pharma to Report Second Quarter 2023 Financial..
03/7/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202311:00GLOBEHOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
01/6/202303:30GLOBEHOOKIPA Pharma Announces Pricing of $50.0 Million Public..
31/5/202322:45GLOBEHOOKIPA Pharma Announces Positive Preliminary Phase 2 Data..
11/5/202313:01GLOBEHOOKIPA Pharma Reports First Quarter 2023 Financial..
09/5/202313:01GLOBEHOOKIPA Announces First Person Dosed in Phase 1a/b Clinical..

Dernières Valeurs Consultées

NASDAQ
HOOK
HOOKIPA Pharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés